133 related articles for article (PubMed ID: 25367951)
1. Ufmylation of ASC1 is essential for breast cancer development.
Cancer Discov; 2014 Nov; 4(11):OF10. PubMed ID: 25367951
[TBL] [Abstract][Full Text] [Related]
2. Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development.
Yoo HM; Kang SH; Kim JY; Lee JE; Seong MW; Lee SW; Ka SH; Sou YS; Komatsu M; Tanaka K; Lee ST; Noh DY; Baek SH; Jeon YJ; Chung CH
Mol Cell; 2014 Oct; 56(2):261-274. PubMed ID: 25219498
[TBL] [Abstract][Full Text] [Related]
3. Modification of ERα by UFM1 Increases Its Stability and Transactivity for Breast Cancer Development.
Yoo HM; Park JH; Kim JY; Chung CH
Mol Cells; 2022 Jun; 45(6):425-434. PubMed ID: 35680375
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-fold modifier 1 acts as a positive regulator of breast cancer.
Yoo HM; Park JH; Jeon YJ; Chung CH
Front Endocrinol (Lausanne); 2015; 6():36. PubMed ID: 25852645
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein.
Singh RR; Barnes CJ; Talukder AH; Fuqua SA; Kumar R
Cancer Res; 2005 Nov; 65(22):10594-601. PubMed ID: 16288053
[TBL] [Abstract][Full Text] [Related]
6. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.
Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y
Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876
[TBL] [Abstract][Full Text] [Related]
8. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
9. Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.
Rajbhandari P; Ozers MS; Solodin NM; Warren CL; Alarid ET
J Biol Chem; 2015 May; 290(22):13749-62. PubMed ID: 25866209
[TBL] [Abstract][Full Text] [Related]
10. [The post-translational modification of estrogen receptor alpha in breast cancer].
Zhao F; Han L; Wu HJ
Sheng Li Ke Xue Jin Zhan; 2012 Jun; 43(3):226-30. PubMed ID: 23019929
[No Abstract] [Full Text] [Related]
11. ERRF is essential for Estrogen-Estrogen Receptor alpha signaling pathway in ER positive breast cancer cells.
Luo A; Zhang X
Biochem Biophys Res Commun; 2016 May; 474(2):400-405. PubMed ID: 27125460
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
[TBL] [Abstract][Full Text] [Related]
13. The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer.
Kameda C; Tanaka H; Yamasaki A; Nakamura M; Koga K; Sato N; Kubo M; Kuroki S; Tanaka M; Katano M
Anticancer Res; 2009 Mar; 29(3):871-9. PubMed ID: 19414322
[TBL] [Abstract][Full Text] [Related]
14. Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein- and equol-induced cell proliferation and estrogen-receptor-alpha-mediated transcription in MCF-7 breast cancer cells.
Liu H; Du J; Hu C; Qi H; Wang X; Wang S; Liu Q; Li Z
J Nutr Biochem; 2010 May; 21(5):390-6. PubMed ID: 19427779
[TBL] [Abstract][Full Text] [Related]
15. [XBP-1 interacts with estrogen receptor alpha (ERalpha)].
Ding LH; Ye QN; Yan JH; Zhu JH; Lü QJ; Wang ZH; Huang CF
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):332-6. PubMed ID: 15971600
[TBL] [Abstract][Full Text] [Related]
16. A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor.
Dong J; Tsai-Morris CH; Dufau ML
J Biol Chem; 2006 Jul; 281(27):18825-36. PubMed ID: 16651265
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.
Das N; Datta N; Chatterjee U; Ghosh MK
Cell Signal; 2016 Jun; 28(6):675-87. PubMed ID: 27012497
[TBL] [Abstract][Full Text] [Related]
18. Altered target gene regulation controlled by estrogen receptor-alpha concentration.
Fowler AM; Solodin NM; Valley CC; Alarid ET
Mol Endocrinol; 2006 Feb; 20(2):291-301. PubMed ID: 16179380
[TBL] [Abstract][Full Text] [Related]
19. RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1.
Gustafsson N; Zhao C; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2010 Feb; 70(3):1265-74. PubMed ID: 20103625
[TBL] [Abstract][Full Text] [Related]
20. Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells.
Cho J; Kim D; Lee S; Lee Y
Mol Endocrinol; 2005 May; 19(5):1191-9. PubMed ID: 15695373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
